ASPA blocking peptide product blog
Tags: Blocking Peptide; Aspa; ASPA blocking peptide;
The ASPA aspa (Catalog #MBS9226386) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The ASPA aspa product has the following accession number(s) (GI #1168340) (NCBI Accession #P45381.1) (Uniprot Accession #P45381). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it act as a scavenger of NAA from body fluids.
Cellular Location: Cytoplasm. Nucleus. Tissue Location: Brain white matter, skeletal muscle, kidney, adrenal glands, lung and liver. ASPA also interacts with the following gene(s): ACY3, CAD. Brain Diseases, Canavan Disease, Disease Models, Animal, Edema, Immune System Diseases, Inflammation, Lung Diseases, Nerve Degeneration, Nervous System Diseases, Pneumonia are some of the diseases may be linked to ASPA Antibody (N-term) Blocking Peptide. Adrenal Gland, Brain, Ganglia, Kidney, Muscle, Skin tissues are correlated with this protein. The following patways have been known to be associated with this gene.